E-DRUG Archives (by date)

• Thread Index

September 28, 2001
• [e-drug] Healy sues UoT for almost $10 million
  • From: Lisa Hayes <lisa@hai.antenna.nl>
• [e-drug] Belgium cuts antibiotic use by 12%
  • From: E-drug <e-drug@usa.healthnet.org>
September 27, 2001
• [e-drug] Contents Prescrire International, Volume 10, Nr 55
  • From: Prescrire International <international@prescrire.org>
• [e-drug] Princess Anne on access to medicines in developing countries
  • From: e-drug@usa.healthnet.org
September 26, 2001
• [e-drug] France to promote sales of generic drugs (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Check-List for fast tract compulsory licensing
  • From: James Love <love@cptech.org>
• [e-drug] Upcoming seminar on access in Europe
  • From: Lisa Hayes <Lisa@hai.antenna.nl>
September 24, 2001
• [e-drug] Effect of supervision on drug management and use
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] France to promote sales of generic drugs (cont'd)
  • From: Pierre Chirac <pierchir@club-internet.fr>
• [e-drug] Universal code for drugs (cont'd)
  • From: Stein Lyftingsmo <sjappe@apotek.no>
• [e-drug] Teaching Aids At Low Cost and CD-ROMs
  • From: Beverley Snell <bev@burnet.edu.au>
September 23, 2001
• [e-drug] Chemical safety information
  • From: Kirsten Myhr <myhr@online.no>
September 22, 2001
• [e-drug] Repeat ordering on antibiotic prescriptions (cont'd)
  • From: Steve Lonsdale <steve@slonsdale.freeserve.co.uk>
• [e-drug] Repeat ordering on antibiotic prescriptions (cont'd)
  • From: Douglas Ball <dball@healthnet.zw>
September 21, 2001
• [e-drug] MSF October Conference Posponed
  • From: David Veazey <Access-NYC@msf.org>
• [e-drug] Acceptable amount of drug wastage due to expiry (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] France to promote sales of generic drugs (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] NEJM this week: Clinical trials ethics (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] NEJM this week: Clinical trials ethics (cont'd)
  • From: Peter Lurie <PLURIE@citizen.org>
• [e-drug] NEJM this week: Clinical trials ethics (cont'd)
  • From: Marc Blockman <mblockmn@uctgsh1.uct.ac.za>
• [e-drug] NEJM this week: Clinical trials ethics (cont'd)
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] France to promote sales of generic drugs
  • From: E-drug <e-drug@usa.healthnet.org>
September 20, 2001
• [e-drug] NEJM this week: Clinical trials ethics
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] David Dollar on globalisation and health
  • From: Hilbrand Haak <haakh@compuserve.com>
• [e-drug] Word Bank position on Globalization, Growth, and Poverty
  • From: Dean Baker <dean.baker@worldnet.att.net>
• [e-drug] Repeat ordering on antibiotic prescriptions (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Repeat ordering on antibiotic prescriptions - further
  • From: David Newby <mddan@alinga.newcastle.edu.au>
• [e-drug] Repeat ordering on antibiotic prescriptions (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
September 19, 2001
• [e-drug] Evidence-based consumer drug information (cont'd)
  • From: Ayesha Ahmed <helpline@thenetwork.org.pk>
• [e-drug] Repeat ordering on antibiotic prescriptions (cont'd)
  • From: Andrea Mant <a.mant@unsw.edu.au>
• [e-drug] Universal code for drugs (cont'd)
  • From: Tony Odendaal <sysman@comed.pwv.gov.za>
• [e-drug] Repeat ordering on antibiotic prescriptions
  • From: David Newby <mddan@cc.newcastle.edu.au>
September 18, 2001
• [e-drug] Heineken to provide ARV therapy to workers in Africa
  • From: e-drug@usa.healthnet.org
• [e-drug] Bloomberg on PhRMA Issue of Newsweek (cont'd)
  • From: James Love <love@cptech.org>
• [e-drug] OXFAM on TRIPS and Medicines
  • From: "Ellen 't Hoen" <ethoen@hotmail.com>
• [e-drug] Global petition on access to medicines & trade
  • From: Anna Mitchel <amitchell@Oxfam.org.uk>
• [e-drug] Qatar: WTO not to block access to treatment
  • From: Olivier Jablonski <jablonski@altern.org>
• [e-drug] MSF statement
  • From: Ingrid Cox <ingrid_cox@msf.org>
September 17, 2001
• [e-drug] selfmedication policies, guidelines, EDL (cont'd)?
  • From: Jerome Reinstein <jreinstein@wsmi.org>
• [e-drug] Comments on the process to revise the WHO Model EDL
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Drug Policy Issues in Developping Countries 2001
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Evidence-based consumer drug information (cont'd)
  • From: Staffan Svensson <staffan.svensson@pharm.gu.se>
• [e-drug] Universal code for drugs (cont'd)
  • From: Alistair Bolt <alistair.bolt@norfolk-norwich.thenhs.com>
• [e-drug] Evidence-based consumer drug information (cont'd)
  • From: Steve Lonsdale <steve@slonsdale.freeserve.co.uk>
• [e-drug] Universal code for drugs (cont'd)
  • From: Stein Lyftingsmo <sjappe@apotek.no>
• [e-drug] Universal code for drugs (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
September 16, 2001
• [e-drug] Role and function of E-drug (cont'd)
  • From: John Urquhart <urquhart@ix.netcom.com>
• [e-drug] African Pharmaceutical Students Federation Launched!
  • From: Joao.L.Carapinha.apsf@yebo.co.za
• [e-drug] Evidence-based consumer drug information
  • From: Alan Cassels <cassels@home.com>
• [e-drug] Universal code for drugs (cont'd)
  • From: Bernhard Edgren <bernhard.edgren@pp.inet.fi>
September 15, 2001
• [e-drug] Ritonavir available at reduced prices to Southern Africa
  • From: e-drug@usa.healthnet.org
• [e-drug] Role and function of E-drug (cont'd)
  • From: Harry van Schooten <H.vSchooten@Inter.NL.net>
• [e-drug] Universal code for drugs
  • From: Mary Ojoo <mojoo@gerties.org>
September 14, 2001
• [e-drug] WHO launches global strategy against antimicrobial resistance
  • From: e-drug@usa.healthnet.org
• [e-drug] Kenya lacks money for buying cheap ARVs
  • From: e-drug@usa.healthnet.org
• [e-drug] MSF and Brazil agree to export generic ARVs
  • From: e-drug@usa.healthnet.org
September 13, 2001
• [e-drug] Therapeutics Letter 41 now on the web
  • From: Ciprian Jauca <jauca@ti.ubc.ca>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Steve Lonsdale <steve@slonsdale.freeserve.co.uk>
• [e-drug] Role and function of E-drug (cont'd)
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] Catastrophe in America
  • From: Manjula Datta <manjulad@yahoo.com>
September 12, 2001
• [e-drug] Catastrophe in America
  • From: Colleen Fuller <cfuller@telus.net>
• [e-drug] Again: Role and function of E-drug
  • From: Hilbrand Haak <haakh@compuserve.com>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Perla Mordujovich <pmordujo@atlas.med.unlp.edu.ar>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Abdullahi Elmi <somali_drugs@yahoo.com>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Vacancy notice - WHO/EDM Traditional Medicines Team
  • From: Jorg Hetzke <hetzkej@who.ch>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Catastroph in America
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] Catastrophe in America
  • From: Rainward Bastian <bastian@difaem.web>
• [e-drug] Role and function of E-drug (cont'd)
  • From: "Ellen 't Hoen" <ehoen@paris.msf.org>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] Drug company sued over research trial in Nigeria (cont'd)
  • From: Patrice Trouiller <PTrouiller@chu-grenoble.fr>
• [e-drug] Drug company sued over research trial in Nigeria (cont'd)
  • From: Pierre Chirac <pierchir@club-internet.fr>
• [e-drug] Role and function of E-drug (cont'd)
  • From: David Henry <mddah@mail.newcastle.edu.au>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Ken Harvey <k.harvey@latrobe.edu.au>
September 11, 2001
• [e-drug] Role and function of E-drug (cont'd)
  • From: Heather Costello <heatherpih@hotmail.com>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Colleen Fuller <cfuller@telus.net>
• [e-drug] pharmacists' role in STI
  • From: e-drug@usa.healthnet.org
• [e-drug] Role and function of E-drug (cont'd)
  • From: Tanne de Goei <aadegoei@chello.nl>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Jennie Lates <jlates@mhss.gov.na>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Ting Kae <tingkae@mail.hukm.ukm.my>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Mary Moran <mary_moran@sydney.msf.org>
• [e-drug] Drug company sued over research trial in Nigeria (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Role and function of E-drug (cont'd)
  • From: David Bratt <dbratt@trinidad.net>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Melissa Raven <melissa.raven@Flinders.edu.au>
• [e-drug] Role and function of E-drug (cont'd)
  • From: "James B. Russo" <jbrusso@aol.com>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Anthony Klouda <lists@klouda.org>
• [e-drug] Role and function of E-drug (cont'd)
  • From: Guido Bakker <guidobakker@planet.nl>
September 10, 2001
• [e-drug] Role and function of E-drug
  • From: Foppe van Mil <jwfvmil@wxs.nl>
• [e-drug] Drug company sued over research trial in Nigeria
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] AIDS expert challenges ethical stance on drug trials
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] Nigeria USD 4m ARV programme
  • From: e-drug@usa.healthnet.org
• [e-drug] South Centre database for publications
  • From: "T. Balasubramaniam" <balasubramaniamt@who.ch>
• [e-drug] Pharmacists' workload (cont'd)
  • From: Foppe van Mil <jwfvmil@wxs.nl>
• [e-drug] Distribution systems, what tracking exists?
  • From: Shawn Bull <h993830@dohho.kzntl.gov.za>
• [e-drug] Unethical AIDS drug trial in Tanzania
  • From: e-drug@usa.healthnet.org
• [e-drug] Pharmaceutical budgets (cont'd)
  • From: Libby Roughead <Libby.Roughead@unisa.edu.au>
• [e-drug] Acceptable amount of drug wastage due to expiry (cont'd)
  • From: Libby Roughead <Libby.Roughead@unisa.edu.au>
September 09, 2001
• [e-drug] Pharmaceutical budgets (cont'd)
  • From: Rokuro Hama <gec00724@nifty.ne.jp>
September 07, 2001
• [e-drug] Storage of drugs matters (cont'd)
  • From: Abdullahi Elmi <somali_drugs@yahoo.com>
• [e-drug] Pharmaceutical budgets (cont'd)
  • From: Kees de Joncheere <CJO@who.dk>
• [e-drug] Drug wastage due to expiry (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Pharmaceutical budgets
  • From: Chung Hae-joo <peasnhr@hotmail.com>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Sinikka Sihvo <sihvo@vjf.inserm.fr>
• [e-drug] Once-Daily Antiretroviral Regimen Safe, Effective
  • From: e-drug@usa.healthnet.org
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Acceptable amount of drug wastage due to expiry (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Acceptable amount of drug wastage due to expiry (cont'd)
  • From: Nicolas de Metz <ndemetz.jsi@pact.mg>
• [e-drug] Acceptable amount of drug wastage due to expiry (cont'd)
  • From: Murray Bailey <murray_b@fsm.ac.fj>
• [e-drug] PBS-PBAC Update - Wooldridge to quit
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
September 06, 2001
• [e-drug] Acceptable amount of drug wastage due to expiry
  • From: Wong Wai See <ycwong@brunet.bn>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Tim Dodd <Cath_and_Tim_Dodd@compuserve.com>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Fawzia Rasheed <rasheedf@bluewin.ch>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Peter Mansfield <peter.mansfield@Flinders.edu.au>
September 05, 2001
• [e-drug] Ephedra ban
  • From: Sidney Wolfe <SWOLFE@citizen.org>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Fawzia Rasheed <rasheedf@bluewin.ch>
• [e-drug] self medication policies, guidelines, EDL? (cont'd)
  • From: Peter Mansfield <peter.mansfield@Flinders.edu.au>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Kim Bessell <kbessell@signet.com.au>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Eve Hurley <eve.hurley@adelaide.edu.au>
• [e-drug] ARVs in Congo, Ghana, Nigeria
  • From: e-drug@usa.healthnet.org
September 04, 2001
• [e-drug] Private health care in developing countries (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Wong Wai See <ycwong@brunet.bn>
• [e-drug] Storage of drugs matters (con't)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] New books
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Murtada Sesay <msesay@unicef.org>
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Peter Mansfield <peter.mansfield@Flinders.edu.au>
• [e-drug] AIDS drugs to be manufactured in Ghana
  • From: e-drug@usa.healthnet.org
September 03, 2001
• [e-drug] Wrong diagnosis and poor nursing (cont'd)
  • From: Gustav Malangu <n.gustav@freemail.absa.co.za>
• [e-drug] HIV/AIDS and Worms?
  • From: e-drug@usa.healthnet.org
• [e-drug] selfmedication policies, guidelines, EDL? (cont'd)
  • From: Patrice Trouiller <PTrouiller@chu-grenoble.fr>
• [e-drug] selfmedication policies, guidelines, EDL?
  • From: Wilbert.Bannenberg.wbannenberg@un.org.za
• [e-drug] Possible confusion over 2 courses in Manila
  • From: David Henry <mddah@mail.newcastle.edu.au>
September 02, 2001
• [e-drug] Pharmacists' workload
  • From: Ogori Taylor <otaylor@infoweb.abs.net>
September 01, 2001
• [e-drug] NYT: Roche Reaches Accord on Drug With Brazil
  • From: Sharonann Lynch <salynch00@earthlink.net>